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Abstract
Background: Perthes’ disease is an idiopathic osteonecrosis of a developmental hip that is most frequent in Northern
Europe. Currently, the absence of a common set of standardised outcomes makes comparisons between studies of
different interventions challenging. This study aims to summarise the outcomes used in clinical research of
interventions for Perthes’ disease and define a set of core outcomes (COS) to ensure that the variables of primary
importance are measured and reported in future research studies investigating Perthes’ disease.
Methods: A systematic review of the current literature will be used to identify a list of outcomes reported in
previous studies. Additional important outcomes will be sought by interviewing a group of children with Perthes’
disease, adults who were treated with the disease in infancy and parents of children with the disease. This list will then
be evaluated by experts in Perthes’ disease using a Delphi survey divided into two rounds to ascertain the importance
of each outcome. The final outcomes list obtained from the Delphi survey will be then discussed during a
consensus meeting of representative key stakeholders in order to define the COS to be reported in future clinical trials
related to Perthes’ disease.
Discussion: The absence of high-quality research and clear guidelines concerning the management of Perthes’ disease
is, at least in part, due to the difficulties in the comparing the results from previous studies. The development of a COS
seeks to standardise outcomes collected in future research studies to enable comparisons between studies to be made
and to facilitate meta-analyses of results.
Trial registration: Core Outcome Measures in Effectiveness Trials Initiative (COMET), 1003. Registered on 20 July 2017.
Prospero International Prospective Register of Systematic Reviews, CRD 42017069742. Registered on 10 July 2017.
Keywords: Core outcomes set, Delphi, Consensus outcomes, Perthes’ disease, Legg-calve-Perthes’ disease
Background
Perthes’ disease is an idiopathic osteonecrosis of the hip
in childhood. It most commonly affects boys aged 4–
8 years [1]. The highest incidence of Perthes’ disease is
in Northern Europe, particularly the Northern part of
the UK [2] and Norway [3]. Perthes’ disease generates a
susceptibility of the femoral head, to change shape, due
to the forces acting across the joint [4, 5]. These shape
changes alter the way that the joint moves, which can
cause lifelong pain, functional limitations and accelerate
the development of osteoarthritis [6].
Clinical treatments focus on the prevention of femoral
head collapse, restoring the range of motion (ROM) and
improving the functional recovery (absence of pain,
amount of usual daily activity and sport-related activity)
of the children [7]. Even though there are many pub-
lished studies investigating the effectiveness of various
surgical or non-surgical treatments, there is no consen-
sus for the best management approach in the paediatric
orthopaedic community [8]. In fact, there are no stand-
ard outcome methods to assess the success of treatment,
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which results in difficulties when trying to make com-
parisons between studies.
The absence of standard outcomes is one of the im-
portant pieces of feasibility information required before
definitive intervention studies can begin. The develop-
ment of core outcome sets (COS), popularised through
the COMET Initiative, is the approach that has been
developed to formulate a set of standardised outcomes
particularly for use in clinical research such as rando-
mised controlled trials (RCT) [9]. COS in clinical trials
seek to reduce heterogeneity of the outcomes, reduce
bias, improve the accuracy of data interpretation and
allow meaningful comparisons between studies facilitat-
ing meta-analysis [9].
Currently, a small number of COS have been devel-
oped within orthopaedic surgery, such as for hip frac-
tures [10] or on generic total joint replacement [11]. To
date, no COS are available to determine the success of
interventions used in the treatment of Perthes’ disease of
the hip in childhood.
Aim and objectives
Aim
The aim of this study is to develop a COS for Perthes’
disease treatment in children, which can be used in clin-
ical and cost effectiveness studies [9].
Objectives
1. Systematically review the current literature to
identify outcomes used in previous studies of
interventions for Perthes’ disease;
2. Identify outcomes important to children and
parents through an interview process;
3. Prioritise the outcomes from key stakeholders, such
as surgeons, physiotherapists and family doctors
using a Delphi survey;
4. Conduct a consensus meeting where the outcome
list will be discussed with all stakeholders and
parent and child representatives to form the core
outcomes list.
Methods/design
Systematic review
The aims of the systematic review are to identify the pri-
mary and secondary outcomes in both operative and
non-operative intervention strategies for Perthes’ dis-
ease. All RCTs, cohort studies and case series that in-
clude patients treated for Perthes’ disease, irrespective of
their treatment type, that report childhood outcomes of
the disease, will be included. Following the PICO (Popu-
lation Intervention Comparison Outcomes) approach,
the inclusion criteria are here summarised:
Population: Children with Perthes’ disease
Intervention and comparator: any treatment
Outcomes: any outcomes
All studies must involve humans and all studies must
be in the English language. This review will be limited to
manuscripts in English, which have been published since
1990. The systematic review aims to generate a list of all
outcomes measures used in the current literature.
Selection of studies
The search strategy will identify all published papers on
the management of Perthes’ disease. Databases involved
in the search will be the Cochrane Library, PubMed and
Web of Science. Multiple databases will be used to
maximise the sensitivity of the search strategy. The time
period searched will be between January 1990 to January
2017.
Eligibility of studies
Studies will be selected by two reviewers (DGL and
WJL) who will screen all the titles and abstracts. Titles
of articles will be reviewed and included or excluded
using Rayyan software [12]. Full text of all the manu-
scripts that match the inclusion criteria or manuscripts
in which the abstract does not give enough information
to make a clear decision about their inclusion will be ob-
tained. This process will be documented with the
PRISMA [13] flow diagram.
Data extraction
Data from eligible studies will be extracted through the
data extraction form (Additional file 1: Appendix S1).
This involves identification of the primary objective, pro-
spective/retrospective data collection, study type, popu-
lation, number of patients, conservative management,
surgical management, primary and secondary outcomes
measured, outcome assessment tools, follow-up.
Data analysis and presentation
All outcomes reported in eligible studies will be ex-
tracted and tabulated with their definition and measure-
ment method(s) and then categorised in domains. To
ensure the comprehensiveness of COS, outcomes terms
will be assigned to one of the five core domains of the
OMERACT [14] framework, that include the areas that
should be covered by outcomes measures in order to en-
sure an adequate reporting of the results. The five do-
mains of the OMERACT filter 2.0. are divided as: (1)
adverse event; (2) life impact; (3) resource use; (4) patho-
physiological manifestations; and (5) death. As suggested
by Dorman et al. [15], the additional sixth domain of
‘technical considerations’, not included in the original
OMERACT filter, will be included in order to assess
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technical or surgical outcomes that surgeons use to
quantify successful outcomes. Under this domain will
also be assessed the feasibility of use in clinical
practice of the reported outcomes [16]. All six areas,
related to the purpose of the review, are listed in
Table 1.
Identification of key outcomes to patients and parents
Overview
Patients and parents’ opinions will be investigated and
integrated in the COS development process through the
identification of patient-reported outcomes (PROs)
through semi-structured interviews administered to the
patients and their parents, in order to assess the life im-
pact of the disease [17]. Patient involvement is a funda-
mental step in defining the COS, following the COMET
guidelines [9]. PROs identified through semi-structured
interviews will be added to outcome list obtained from
the systematic review. The full list will then be submit-
ted for the experts’ evaluation through round 1 of the
Delphi Survey.
Interview process
In order to determine the PROs for children with
Perthes’ disease, the process will include two stages
(Fig. 1):
1. Parents will be interviewed through a semi-structured
interview process;
2. Children, with the help of the parents and/or of the
interviewers (if needed), will complete a bespoke
booklet to report their PROs. This booklet was
initially designed with the help of two families
affected by Perthes’ disease to ensure that it was
sufficient to extract all of the relevant information.
The booklet is used as a prompt to develop further
discussion with the children.
Sample size will ensure insight into a diverse range of
parent and child perspectives. We aim to recruit up to
40 participants, 20 with parents and 20 with their child
with Perthes’ disease. The sample size estimation is
based on general qualitative research guidelines [18] and
it will be deemed complete when there will be agree-
ment that saturation is reached, with no new outcome
domains generated. The sample will purposively select a
range of children aged 5–16 years, both boys and girls,
at different stage of the disease (pre or post surgery, or
treated with conservative approaches). The aim is to
provide a richness in perspectives while remaining
Table 1 Modified OMERACT filter 2.0. core areas
Core area Core domains Example(s)
Adverse events Adverse events Unintended consequences
Life impact Physical/Social/Emotional/ Cognitive/Health-Related
quality of life
Quality of life, pain, impact on family, absence from
school, participation in sports activities, functional
scores – hip ROM and gait impairments
Resource use Economic/Hospital/Need for intervention/Social burden Length of stay, further surgery, physiotherapy
Pathophysiological manifestations Musculoskeletal Femoral head collapse, healing process, impingement
Death N/A N/A
Technical considerations Technical/Surgical considerations Radiographic measurement
Feasibility of use in clinical practice
Fig. 1 Schematic of the interview process
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feasible within resource constraints. Data representing a
variety of perspectives and from a diverse sample help to
enhance the credibility of findings by demonstrating that
the researcher has sought to present a balanced picture
and not favoured one particular viewpoint or perspective
[19]. Participants will be selected from patients attending
Alder Hey Children’s Hospital Liverpool (UK), from
members of the Perthes’ Association (UK) and via fam-
ilies known to the International Perthes’ Disease Study
Group (IPSG).
Inclusion into this part of the study for children (and
their parents) are related to the history of Perthes’ dis-
ease in the child (irrespective of the current stage of dis-
ease and treatment method) and the ability to be
conversant in English.
Interview format
Among parents, a semi-structured interview will be
used. Informed consent will be collected from the partic-
ipants before the interview. The parent(s) of each child
will be interviewed in a session that will last approxi-
mately 30 min. The interview will comprise a series of
open-ended questions on their experiences and impact
of the Perthes disease on their everyday life. The inter-
views aim to collect participants’ experience of the dis-
ease and the impact of Perthes’ disease on their lives,
evaluating the daily needs that they have to deal with.
The questions will investigate areas such as impact of
the disease on patients and related family, the import-
ance of clinical management, the impact of the disease
on daily living activities and sport/recreational activities.
Thus, based on our pilot work, the interview will be di-
rected to the importance of defining key outcomes in
the treatments and identifying possible outcomes in the
management of Perthes’ disease. In the children’s group,
a booklet (Additional file 2: Appendix S2) including
questions related to Perthes’ disease and its influence in
the child daily life, will be completed by each child, with
the help of the interviewers where needed. The booklet
aims to be a prompt for further discussion involving
children and contains questions related to pain, hip mo-
bility, related influence of the disease in the daily activ-
ities and effects of the treatment(s), explained through
the use of emoji to ensure ease of completion. The final
part of the booklet includes a personal description of a
recent bad day and good day experienced by the child.
This last part will be transcribed in children aged <
8 years (which will be helped by the interviewers) and
recorded as an open-question interview in children aged
> 8 years. The booklet completion process takes no lon-
ger than 30 min.
Consultation with the Health Research Authority
deemed this study a service evaluation project with no
requirement for ethical approval (reference 60/89/81).
Informed consent will be assumed if participants agree
to fill in the survey. A consent form indicating informed
consent will be signed by parents to agree participation
in the interview and allow voice recording of the
interviews.
Interview analysis
All interviews will be recorded and transcribed; then, the
transcripts and the recordings will be analysed in line
with the qualitative approach following the National
Centre for Research Methods guidelines [20].
The process of analysis of the qualitative data will
summarise and define the key outcomes based on the
stakeholders’ opinion.
Identification of key outcomes to clinicians
Overview
A Delphi survey [21] (Fig. 2) will be conducted to iden-
tify the key outcomes important to orthopaedic sur-
geons, GPs and physiotherapists. The Delphi approach is
a consensus technique that involves a series of question-
naires administered to target experts in the investigated
area, which answer in an anonymous way in order to re-
duce reciprocal influences and bias [21].
Identification of potential outcomes
A complete list of all the outcomes present in the litera-
ture will be made following the approach of the system-
atic review described in this protocol. Additional
outcomes will be included following the PROs obtained
by the patients/parents’ interviews. Each outcome will
be listed both individually and by domain.
Participants
Previous studies have indicated that a sample size of at
least 20 clinicians is adequate in order to achieve the
main goals of COS studies [22]. Participants will be
those with experience of managing children with
Perthes’ disease. This group of experts will include
orthopaedic surgeons, GPs and physiotherapists, includ-
ing both UK experts and an overseas experts group. The
clinicians involved in the study will be selected through
the British Society of Children’s Orthopaedic Surgery
(BSCOS) and the International Perthes’ Disease Study
Group (IPSG). Participants will be contacted and invited
to participate in the survey by email using a bespoke
COS Delphi management tool.
Delphi survey
The survey will be based on two stages (rounds). Clini-
cians involved in the study will have a three-week time
period to complete each stage of the survey.
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Delphi round 1
The electronic data collection form will seek details of
participants’ demographic data (participant name, clin-
ical role, place of work and contacts), seek the important
list of selected outcomes (from the review and the pa-
tients/parents’ interviews) (to be graded on a score of 1–
9 with ‘1–3 = not relevant’; ‘4–6 = important but not
critical’; and ‘6–9 = extremely relevant’) and will give the
possibility to add additional outcomes considered of im-
portance (and related scores) not listed in the list.
Analysis of Delphi round 1
The analysis of the data will summarise the outcomes
considered most important. Additional outcomes added
by the clinicians will be reviewed by two assessors (DGL
and WJL) in order to ensure that they do not refer to
outcomes already listed. The number of the invited par-
ticipants that respond to the survey will also be
recorded.
Delphi round 2
At the second stage, participants involved in round 1 of
the Delphi survey will be able to see the summary of the
data obtained in round 1, asking them to review again
the list of outcomes, considering if the outcomes present
in the summarised list have to be classified as relevant
or not.
Participants that do not respond to round 1 will be ex-
cluded in round 2.
Analysis of Delphi round 2
The total number of participants invited to participate
and do participate in round 2 will be recorded. The dis-
tribution of scores will be summarised. In the summary
of the percentage agreement, each individual outcome
will be classified as ‘consensus in’, ‘consensus out’ or ‘no
consensus’ based on the percentage.
Consensus meeting
The final stage of the study will be based on a consensus
meeting between a selected group of clinicians and a se-
lected group of patients/parents (for a total of 24 partici-
pants, adhering to the OMERACT guidelines for the
consensus meeting structure [14]).
Before the meeting, the patients/parents group will be
able to review the outcomes selected by the clinicians
during the Delphi survey and these data will be dis-
cussed during the consensus meeting.
Definition of consensus
Following the GRADE guidelines [23], in order to de-
fine consensus, outcomes inclusion will be indicated
as the agreement by the vast majority (> 70% of the
group) of the ‘extremely relevant’ (7–9 points range)
of the discussed outcomes, with only a minority (<
15% of the group) of participants that consider it as
‘not relevant’ (1–3 points range). Consensus for out-
comes exclusion will be indicated as the agreement
by the vast majority (> 70% of the group) of the ‘not
relevant’ (1–3 points range) of the discussed
Fig. 2 Schematic summary of Delphi Survey Process
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outcomes, with only a minority (< 15% of the group)
of participants that consider it as ‘extremely relevant’
(7–9 points range).
Discussion
The evaluation of literature on Perthes’ disease shows a
clear lack of common outcome measures reported
among different studies in the literature. This lack of a
COS impacts the ability to produce meaningful research
and inhibits the ability to compare research findings in
order to clearly define the management guidelines for
Perthes’ disease. Thus, a clear definition and implemen-
tation of a COS is required in order to help future re-
searchers identify the primary outcome measures in
their studies in order to increase the quality and the
clinical application of the results obtained.
Trial status
The systematic review and the patients’ recruitment for
the interview process is currently ongoing.
Search strategies
PubMed search strategy: 1 January 1990 to 1 January
2017
1. ‘Femur Head Necrosis’ [MeSH]
2. Osteonecrosis [MeSH]
3. (Perthe* OR Legg-Calv*-Perthe* OR Legg-Perthe*
OR Calv*-Perthe*)
4. (Perthe* AND Legg-Calv*-Perthe* AND Legg-
Perthe* AND Calv*-Perthe*)
5. (#1 OR #2 OR #3 OR #4) AND Hip*
6. (#5) AND (Child* OR Infant*)
Cochrane CENTRAL search strategy: 1 January 1990
to 1 January 2017
1. MeSH descriptor: [Femur Head Necrosis] explode
all trees
2. MeSH descriptor: [Osteonecrosis] explode all trees
3. (TITLE-ABSTRACT-KEYWORDS) Perthe* OR
Legg-Calv*-Perthe* OR Legg-Perthe* OR Calv*-
Perthe*
4. (TITLE-ABSTRACT-KEYWORDS) Perthe* AND
Legg-Calv*-Perthe* AND Legg-Perthe* AND Calv*-
Perthe*
5. (TITLE-ABSTRACT-KEYWORDS) (#3 OR #4)
AND Hip*
6. (TITLE-ABSTRACT-KEYWORDS) (#5) AND
(Child* OR Infant*)
Web of Science search strategy: 1 January 1990 to 1
January 2017
1. (TOPIC) ‘Femur Head Necrosis’
2. (TOPIC) Osteonecrosis
3. (TOPIC) Perthe* OR Legg-Calv*-Perthe* OR Legg-
Perthe* OR Calv*-Perthe
4. (TOPIC) Perthe* AND Legg-Calv*-Perthe* AND
Legg-Perthe* AND Calv*-Perthe*
5. (TOPIC) (#1 OR #2 OR #3 OR #4) AND Hip*
6. (TOPIC) (#5) AND (Child* OR Infant*)
Additional files
Additional file 1: Appendix S1. Systematic review data extraction form.
(DOCX 20 kb)
Additional file 2: Appendix S2. Children’s booklet. (DOCX 242 kb)
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